{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:04:48Z","timestamp":1789491888377,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007697","name":"Northern Advancement Center for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K18816"],"award-info":[{"award-number":["JP24K18816"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijpt.2026.101951","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:45:22Z","timestamp":1784130322000},"page":"101951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical Comparison of Beam-Specific Planning Target Volume Single-Field Uniform Dose and Robust Intensity-Modulated Proton Therapy in Ultra-Hypofractionation for Prostate Cancer"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7702-2357","authenticated-orcid":false,"given":"Hiroshi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishin","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijpt.2026.101951_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101951_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101951_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.ijpt.2026.101951_bib4","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10196","key":"10.1016\/j.ijpt.2026.101951_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijpt.2026.101951_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101951_bib7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijpt.2026.101951_bib9","article-title":"The status and challenges for prostate stereotactic body radiation therapy treatments in United States Proton Therapy Centers: an NRG oncology practice survey","volume":"11","author":"Shen","year":"2024","journal-title":"Int J Part Ther"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101951_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13014-016-0761-0","article-title":"Treatment planning comparison of IMPT, VMAT and 4\u03a0 radiotherapy for prostate cases","volume":"12","author":"Tran","year":"2017","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cancers16020403","article-title":"Dosimetric comparison study of proton therapy using line scanning versus passive scattering and volumetric modulated arc therapy for localized prostate cancer","volume":"16","author":"Takagi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1021","key":"10.1016\/j.ijpt.2026.101951_bib12","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20120288","article-title":"Treatment planning optimisation in proton therapy","volume":"86","author":"McGowan","year":"2013","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101951_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijrobp.2014.04.019","article-title":"Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice","volume":"89","author":"Frank","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101951_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1088\/0031-9155\/53\/4\/014","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101951_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1088\/0031-9155\/53\/4\/015","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/0284186X.2012.752860","article-title":"Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets","volume":"52","author":"Th\u00f6rnqvist","year":"2013","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib17","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.ijrobp.2011.05.011","article-title":"A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties","volume":"82","author":"Park","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101951_bib18","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1088\/0031-9155\/52\/10\/009","article-title":"Accounting for range uncertainties in the optimization of intensity modulated proton therapy","volume":"52","author":"Unkelbach","year":"2007","journal-title":"Phys Med Biol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101951_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1088\/0031-9155\/53\/6\/013","article-title":"Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy","volume":"53","author":"Pflugfelder","year":"2008","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib20","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1118\/1.3556559","article-title":"Minimax optimization for handling range and setup uncertainties in proton therapy","volume":"38","author":"Fredriksson","year":"2011","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prro.2014.05.008","article-title":"Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility","volume":"5","author":"Kirk","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101951_bib22","volume":"6","author":"Wang","year":"2022","journal-title":"Ther Radiol Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib23","doi-asserted-by":"crossref","DOI":"10.1118\/1.4774363","article-title":"PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization","volume":"40","author":"Liu","year":"2013","journal-title":"Med Phys"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101951_bib24","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1118\/1.4962933","article-title":"Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT","volume":"43","author":"Kurz","year":"2016","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101951_bib25","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/3\/1\/015003","article-title":"A comprehensive evaluation of the accuracy of CBCT and deformable registration based dose calculation in lung proton therapy","volume":"3","author":"Veiga","year":"2017","journal-title":"Biomed Phys Eng Express"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101951_bib26","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab7d54","article-title":"Comparison of CBCT based synthetic CT methods suitable for proton dose calculations in adaptive proton therapy","volume":"65","author":"Thummerer","year":"2020","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.14338\/IJPT-14-00024.1","article-title":"Cone-beam computed tomography and deformable registration-based \u201cDose of the Day\u201d calculations for adaptive proton therapy","volume":"2","author":"Veiga","year":"2015","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijpt.2026.101951_bib28","unstructured":"Prostate Cancer (Version 1.2025). National Comprehensive Cancer Network2025. Accessed May 15, 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.ijpt.2026.101951_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phro.2021.09.006","article-title":"A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer","volume":"20","author":"Yoshimura","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101951_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2021.03.002","article-title":"Visualizing the urethra by magnetic resonance imaging without usage of a catheter for radiotherapy of prostate cancer","volume":"18","author":"Yoshimura","year":"2021","journal-title":"Phys Imag Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101951_bib31","article-title":"A single-institution prospective study to evaluate the safety and efficacy of real-time image-gated spot-scanning proton therapy (RGPT) for prostate cancer","volume":"9","author":"Nishioka","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101951_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ejmp.2016.08.007","article-title":"NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies\u2014A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT)","volume":"32","author":"Yoshimura","year":"2016","journal-title":"Phys Med"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101951_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13531","article-title":"Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer","volume":"23","author":"Tamura","year":"2022","journal-title":"J Appl Clin Med Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2019.02.002","article-title":"Deformable registration for dose accumulation","volume":"29","author":"Chetty","year":"2019","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101951_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13014-021-01933-z","article-title":"Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer","volume":"16","author":"Tamihardja","year":"2021","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/iim.11.22","article-title":"Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU report 83","volume":"3","author":"Gregoire","year":"2011","journal-title":"Imag Med"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate","volume":"37","author":"van't Riet","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101951_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(01)01453-5","article-title":"Organ motion and its management","volume":"50","author":"Langen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101951_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.103938","article-title":"Evaluation of radiotherapy plan robustness: a systematic literature review","volume":"48","author":"Kim","year":"2025","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijpt.2026.101951_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2022.05.038","article-title":"Dose and robustness comparison of nominal, daily and accumulated doses for photon and proton treatment of sinonasal cancer","volume":"173","author":"Argota-Perez","year":"2022","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2017.11.005","article-title":"Robust proton treatment planning: physical and biological optimization","volume":"28","author":"Unkelbach","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1118\/1.3679340","article-title":"Robust optimization of intensity modulated proton therapy","volume":"39","author":"Liu","year":"2012","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101951_bib43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2014.10.014","article-title":"Rectal toxicity after intensity modulated radiotherapy for prostate cancer: Which rectal dose volume constraints should we use?","volume":"113","author":"Fonteyne","year":"2014","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101951_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijrobp.2006.10.042","article-title":"Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer","volume":"67","author":"Cheung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101951_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ijrobp.2015.04.006","article-title":"Assessing the clinical impact of approximations in analytical dose calculations for proton therapy","volume":"92","author":"Schuemann","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101951_bib46","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1118\/1.4745558","article-title":"Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study","volume":"39","author":"Matsuura","year":"2012","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101951_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijrobp.2013.05.048","article-title":"Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment","volume":"87","author":"Tang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026006542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026006542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:28:17Z","timestamp":1789489697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518026006542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S2331518026006542"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101951","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Comparison of Beam-Specific Planning Target Volume Single-Field Uniform Dose and Robust Intensity-Modulated Proton Therapy in Ultra-Hypofractionation for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101951"}}